Status:
WITHDRAWN
VR for Joint Attention Support in ASD
Lead Sponsor:
Floreo, Inc.
Conditions:
Autism Spectrum Disorder
Eligibility:
All Genders
7-17 years
Phase:
PHASE2
Brief Summary
The overall objective of this study is to determine the effectiveness of the Floreo VR Joint Attention Module in improving social communication skills in children with ASD. An additional objective is ...
Detailed Description
The study will be a Phase II randomized controlled trial in which the Floreo VR Joint Attention Module is the intervention being evaluated. Floreo is a mobile application that offers a supervised virt...
Eligibility Criteria
Inclusion
- Documented ASD diagnosis, between 7 and 17 years of age
Exclusion
- History of seizures, migraines, vertigo, psychosis
Key Trial Info
Start Date :
July 20 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 16 2019
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04016701
Start Date
July 20 2018
End Date
July 16 2019
Last Update
July 17 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's SPOT
Columbia, Maryland, United States, 21045